Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Halozyme Therapeutic (HALO)

Halozyme Therapeutic (HALO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,856,651
  • Shares Outstanding, K 135,213
  • Annual Sales, $ 443,310 K
  • Annual Income, $ 402,710 K
  • 60-Month Beta 1.23
  • Price/Sales 12.39
  • Price/Cash Flow 26.57
  • Price/Book 75.69
Trade HALO with:

Options Overview Details

View History
  • Implied Volatility 36.67% ( +3.69%)
  • Historical Volatility 38.91%
  • IV Percentile 16%
  • IV Rank 17.94%
  • IV High 70.95% on 02/16/22
  • IV Low 29.18% on 01/10/23
  • Put/Call Vol Ratio 0.46
  • Today's Volume 423
  • Volume Avg (30-Day) 427
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 10,908
  • Open Int (30-Day) 12,557

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 0.43
  • Number of Estimates 6
  • High Estimate 0.49
  • Low Estimate 0.38
  • Prior Year 0.39
  • Growth Rate Est. (year over year) +10.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
48.97 +3.55%
on 01/11/23
57.81 -12.28%
on 12/29/22
-6.41 (-11.22%)
since 12/27/22
3-Month
45.21 +12.17%
on 11/08/22
59.46 -14.72%
on 12/02/22
+3.71 (+7.89%)
since 10/27/22
52-Week
31.36 +61.70%
on 01/28/22
59.46 -14.72%
on 12/02/22
+18.74 (+58.62%)
since 01/27/22

Most Recent Stories

More News
Market on Tipping Point of New Bull Trend: These 5 Charts Illustrate Why

You never really know when a new bull trend has arrived for sure. However, by looking at different sides of the market you can begin to put the pieces of the puzzle together.

AAPL : 145.93 (+1.37%)
MSFT : 248.16 (+0.06%)
JNJ : 168.23 (-0.39%)
XOM : 115.61 (-1.83%)
TXRH : 98.96 (-0.08%)
HALO : 50.71 (-4.82%)
TSLA : 177.90 (+11.00%)
IBB : 137.23 (+0.05%)
QQQ : 296.26 (+1.00%)
SPY : 405.68 (+0.23%)
IWM : 189.58 (+0.54%)
MTDR : 67.28 (-2.12%)
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

Smart Beta ETF report for XBI

XBI : 89.39 (+0.90%)
BIIB : 290.08 (-0.63%)
HALO : 50.71 (-4.82%)
IBB : 137.23 (+0.05%)
HZNP : 110.63 (-0.56%)
FBT : 163.66 (+0.13%)
Halozyme (HALO) Down 9.2% on Weak 2023 Financial Guidance

Though Halozyme (HALO) expects a year-over-year increase in revenues and earnings for 2023, the company's guidance fell short of Wall Street expectations.

RHHBY : 39.2900 (-0.23%)
JNJ : 168.23 (-0.39%)
HALO : 50.71 (-4.82%)
ARGX : 380.90 (-0.31%)
Should You Invest in the SPDR S&P Biotech ETF (XBI)?

Sector ETF report for XBI

XBI : 89.39 (+0.90%)
BIIB : 290.08 (-0.63%)
HALO : 50.71 (-4.82%)
IBB : 137.23 (+0.05%)
HZNP : 110.63 (-0.56%)
FBT : 163.66 (+0.13%)
HALOZYME THERAPEUTICS, INC. ANNOUNCES REDEMPTION OF 1.25% CONVERTIBLE SENIOR NOTES DUE 2024

/PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that it has elected to redeem on March 17, 2023 (the "Redemption Date")...

HALO : 50.71 (-4.82%)
Halozyme Provides 2023 Financial Guidance and Outlook

/PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced its 2023 financial guidance and commented on its outlook for the upcoming year....

HALO : 50.71 (-4.82%)
Should iShares Russell 2000 Growth ETF (IWO) Be on Your Investing Radar?

Style Box ETF report for IWO

IWO : 234.15 (+0.48%)
EME : 146.58 (+0.16%)
HALO : 50.71 (-4.82%)
IJT : 114.73 (+0.11%)
VBK : 222.53 (+1.04%)
SWAV : 187.83 (-3.50%)
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

HALO : 50.71 (-4.82%)
Zacks.com featured highlights Halozyme Therapeutics, Arista Networks and Citizens Financial Group

Halozyme Therapeutics, Arista Networks and Citizens Financial Group have been highlighted in this Screen of The Week article.

HALO : 50.71 (-4.82%)
ANET : 126.06 (+1.67%)
CFG : 43.29 (+0.39%)
3 Stocks to Keep an Eye on for Earnings Growth in 2023

As 2023 approaches, its prudent to have a look at stocks like Halozyme Therapeutics (HALO), Arista Networks (ANET) & Citizens Financial Group (CFG) for solid earnings growth.

HALO : 50.71 (-4.82%)
ANET : 126.06 (+1.67%)
CFG : 43.29 (+0.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Halozyme Therapeutics Inc. is a biopharmaceutical company, focused on the development and commercialization of novel treatments for oncology indications by targeting tumor microenvironment. The company's ENHANZE drug delivery technology helps in developing subcutaneous formulation of drugs. The company...

See More

Key Turning Points

3rd Resistance Point 56.51
2nd Resistance Point 54.92
1st Resistance Point 52.81
Last Price 50.71
1st Support Level 49.12
2nd Support Level 47.53
3rd Support Level 45.42

See More

52-Week High 59.46
Last Price 50.71
Fibonacci 61.8% 48.73
Fibonacci 50% 45.41
Fibonacci 38.2% 42.09
52-Week Low 31.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar